Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
USFDA gives tentative approval to Lupin’s Dolutegravir and Rilpivirine tablets
The tablets are used to treat HIV infection
DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster…
The DCGI's approval came following recommendation by the Subject Expert Committee (SEC) of the Central Drugs Standard Control…
AbbVie and Eli Lilly exit UK drug pricing agreement
The Association of British Pharma Industry (ABPI) said it was seeking early talks with the government to set out a new future…
Eisai files for approval of Alzheimer’s drug in Japan
The drug, developed in partnership with Biogen, is an antibody that has been shown to remove sticky deposits of a protein called…
The Indian scenario of rare Lysosomal Storage Disorders, diagnostic and treatment approaches
Dr Vibhuti Jain Rana (VJR), Head, Medical, Neovation Consultancy Services, a global medical affairs pharma partner, recently took…
China allows sale of Pfizer oral drug as demand surges in wake of rising COVID cases
The agreement is valid between 14th December and 30th November, 2023, China Meheco said in a filing to the Shanghai stock exchange
USFDA gives tentative approval to Zydus’s Levomilnacipran extended-release capsules
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
EMA seeks to issue guidance on liver damage from Novartis’s gene therapy
The statement follows recent deaths due to liver failure after treatment with the gene therapy, the EMA said
European shares inch up on pharma boost, set to post second weekly gain
The pan-regional STOXX 600 gained 0.2 per cent by 0811 GMT, while the UK's FTSE 100 added 0.4 per cent after data showed British…
Serum Institute’s free supply of Covishield to Centre : First lot of 80 lakh doses set for dispatch
Since the launch of the anti-COVID vaccination drive, SII has so far provided 170 crore doses of Covishield to the government